Ownership history in CM Management, LLC · 20 quarters on record
This page tracks every 13F SEC filing in which CM Management, LLC reported a position in CYTOSORBENTS CORP (CTSO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 1,476,500 | +188,372 | +14.6% | 0.80% | $944K | $0.64 |
| 2025 Q3 | ADDED | 1,288,128 | +38,128 | +3.1% | 1.00% | $1.2M | $0.93 |
| 2025 Q2 | ADDED | 1,250,000 | +295,924 | +31.0% | 1.46% | $1.6M | $1.28 |
| 2025 Q1 | ADDED | 954,076 | +254,076 | +36.3% | 0.96% | $954K | $1.00 |
| 2024 Q4 | REDUCED | 700,000 | -100,000 | -12.5% | 0.57% | $637K | $0.91 |
| 2024 Q3 | REDUCED | 800,000 | -50,000 | -5.9% | 0.96% | $1.2M | $1.50 |
| 2024 Q2 | ADDED | 850,000 | +25,000 | +3.0% | 0.55% | $598K | $0.70 |
| 2024 Q1 | ADDED | 825,000 | +410,000 | +98.8% | 0.66% | $784K | $0.95 |
| 2023 Q4 | REDUCED | 415,000 | -35,000 | -7.8% | 0.37% | $461K | $1.11 |
| 2023 Q3 | UNCHANGED | 450,000 | — | 0% | 0.90% | $846K | $1.88 |
As of 2025 Q4 — sorted by position size